Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-25-052135
Filing Date
2025-05-23
Accepted
2025-05-22 21:30:37
Documents
8

Document Format Files

Seq Description Document Type Size
1 S-3 tm2515651-1_s3asr.htm S-3 645922
2 EXHIBIT 1.4 tm2515651d2_ex1-4.htm EX-1.4 14000
3 EXHIBIT 1.5 tm2515651d2_ex1-5.htm EX-1.5 23834
4 EXHIBIT 4.8 tm2515651d2_ex4-8.htm EX-4.8 452296
5 EXHIBIT 5.1 tm2515651d2_ex5-1.htm EX-5.1 28672
6 EXHIBIT 23.2 tm2515651d2_ex23-2.htm EX-23.2 2774
7 EX-FILING FEES tm2515651d2_ex-filingfees.htm EX-FILING FEES 33988
8 GRAPHIC lg_replimue-4c.jpg GRAPHIC 28563
  Complete submission text file 0001104659-25-052135.txt   1241945
Mailing Address 500 UNICORN PARK WOBURN MA 01801
Business Address 500 UNICORN PARK WOBURN MA 01801 (781) 222-9600
Replimune Group, Inc. (Filer) CIK: 0001737953 (see all company filings)

EIN.: 822082553 | State of Incorp.: DE | Fiscal Year End: 0331
Type: S-3 | Act: 33 | File No.: 333-287536 | Film No.: 25979035
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)